Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Open in API
Filings indexed 968 across all filing types
Latest filing 2024-05-13 Board/Management Inform…
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
ArcticZymes Technologies - changes to the Board of Directors
Board/Management Information Classification · 100% confidence The document explicitly announces 'changes to the Board of Directors,' including the nomination of new members and the resignation of the Chairman and another Board member. This content directly aligns with the definition of Board/Management Information. Although it mentions the AGM date change, the primary focus and bulk of the text concern the composition of the Board. Therefore, the most specific and accurate classification is MANG.
2024-05-13 English
ArcticZymes Technologies - changes to the Board of Directors
Board/Management Information Classification · 100% confidence The document explicitly announces 'changes to the Board of Directors,' detailing the resignation of the Chairman and a Board member, and the nomination of new Board members. This content directly aligns with the definition of Board/Management Information (MANG). Although it mentions the AGM date change, the primary focus and bulk of the text concern the governance structure changes (Board composition). The document length is relatively short (3900 chars), but it is a substantive announcement, not just a notice that a report is attached, thus ruling out RPA/RNS based on the 'MENU VS MEAL' rule for substantive content.
2024-05-13 English
ArcticZymes Technologies Q1 2024 Results
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive '1st Quarter Quarterly Report' for ArcticZymes Technologies (AZT) for Q1 2024. It contains detailed financial statements, operational reviews, segment analysis (Biomanufacturing and Molecular Tools), cash flow analysis, and risk factors. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report. Q1 2024
2024-05-08 English
ArcticZymes Technologies ASA Q1 2024 Presentation
Investor Presentation Classification · 100% confidence The document is a slide deck titled 'Q1 2024 update' presented by the CEO and CFO. It contains strategic priorities, sales updates, product highlights, and market analysis for the first quarter of 2024. As it is a presentation deck used to communicate financial and operational performance to investors, it falls under the category of an Investor Presentation. Q1 2024
2024-05-08 English
ArcticZymes Technologies ASA Q1 2024 Presentation
Report Publication Announcement Classification · 98% confidence The document is titled 'ArcticZymes Technologies ASA Q1 2024 Presentation' and explicitly states that the company 'presents on May 8, 08:30 CET its interim report for the first quarter 2024'. It also says 'Please find the presentation attached.' Since the document is very short (459 chars) and serves primarily to announce the presentation of the Q1 results/interim report, it fits the definition of a Report Publication Announcement (RPA) rather than the full Interim Report (IR) itself. The content is an announcement about the release/presentation of financial information.
2024-05-08 English
ArcticZymes Technologies ASA: Invitation to presentation of Q1 2024 results
Report Publication Announcement Classification · 98% confidence The document is very short (902 characters) and explicitly serves as an 'Invitation to presentation of Q1 2024 results'. It announces the time and method for viewing the presentation of the Q1 2024 results and states that the actual Q1 2024 report will be available separately on newsweb.no and the company homepage at 07:00 CET. Because this document is an announcement about the upcoming release/presentation of results, rather than the results themselves (ER) or the comprehensive report (IR), it fits best under Report Publication Announcement (RPA), as it announces the publication/presentation of the Q1 report.
2024-05-03 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.